All Green in Tennessee … Daniel Hemric has the green light this week at Bristol Motor Speedway (BMS) with a fresh look and ...

Mumbai: A day after the state government issued a Government Resolution (GR) clarifying the roadmap for the implementation of ...

Evotec SE (NASDAQ:EVO) Q4 2025 Earnings Call Transcript April 8, 2026 Evotec SE reports earnings inline with expectations. Reported EPS is $0.2098 EPS, expectations were $0.2098. Operator: Ladies and ...

Managing uncertainty is also at the core of business—especially when your business is developing life-changing medicine, said ...

With recent equipment package changes from NASCAR and Goodyear for its Cup Series short track and road course races, the Food ...

Shanda Nikolajski, Belleview Middle School 8th grade student counselor, is the latest/Florida Credit Union Amazing Teacher of ...

Discover EV battery advancements, safety, and market trends at MD&M South & The Battery Show South in Charlotte this April.

Want a new action flick to devour? We've got some quick picks for you on Paramount+.

Bristol Myers Squibb and Johnson & Johnson have said they will stop development of their oral Factor XIa inhibitor milvexian in acute coronary syndrome after a disappointing trial result. The decision ...

Bristol Myers Squibb has the first positive phase 3 results under its belt for mezigdomide, a second experimental drug in its much-trumpeted celmod development programme for multiple myeloma. Interim ...

Johnson & Johnson’s immunology drug Tremfya is looking to challenge AbbVie’s dominance in 2026, securing the top spot as the ...

Envudeucitinib, a tyrosine kinase 2 (TYK2) inhibitor, demonstrated rapid improvement and progressively deepening skin ...